(438) 288-2826 Helping seniors. Live better. Longer.

Intellectual Property


Medipense logo 300px web [PNG]All information, documents, products, software, services and other materials displayed on this site are the property and copyrighted work of Medipense Inc., or a third party provider. All trademarks and logos are the property of Medipense Inc., or their respective owners. Nothing on this site shall be construed as granting by any means or implication, any license or right to use any trademark, logo or service mark, registered or unregistered, displayed on the site without the owner’s prior written permission, except as otherwise described herein. RxPense logo 300px web [PNG]Medipense Inc., reserves all rights not expressly granted in and to the site and its content. This site and all of its content, including but not limited to text, design, graphics, interfaces and code, and the selection and arrangement thereof, is protected under the copyright laws of Canada and other countries.

Some trademarks owned by Medipense Inc.: TMA917574, TMA917578, TMA998891, APP1965443, US4,731,151, US5,736,724, AUS1980642, AUS1980643


The RxPense Hub, Portal, dispensing solutions and processes are manufactured under patent protection or patent-pending status in Canada, the USA, countries of the European Union including the United Kingdom, France, Germany and others.

Some patents & industrial designs owned by Medipense Inc.,: US10.343.806, US10.065.788, EU15 818 249.3, EU10343806, CA2953399, CA2953624, CA2960593.


The RxPense Hub is manufactured under design patent protection or patent-pending status in Canada the USA. The design patent protects the appearance of a the RxPense, while the utility patents cover its structural and functional features. An effective design appeals to the consumer and may even create an emotional connection between the consumer, the product, and the brand. This is why a novel design is considered to be valuable intellectual property.

Industrial designs owned by Medipense Inc.,: CA 158164, US D773,175 S.

For any information regarding Medipense IP strategy, licensing, or use agreements, please contact us with your request.

IP Strategy

Medipense focuses on innovation and research that is central to the company’s core business goals. Our research & development into advanced technologies and AI in an effort to increase reliability and broaden utilization, is one such example. Medipense is interested in exploring other technologies which complement the RxPense in order to create higher value solutions. We also expect to licence our IP to others for medication dispensing and agricultural products that may be similarly packaged.

Pin It on Pinterest